Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Talactoferrin alfa in severe sepsis
NCT00630656Phase 2Completed
- Sponsor
- Agennix AG
- Start
- Apr 2008
- Primary completion
- Aug 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 5
01
Overview
A Phase 2 trial of lactoferrin in sepsis, sponsored by Agennix AG. Started Apr 2008; status: completed.
02
Drugs
lactoferrin
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT00630656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00630656.